Evidence map›Paper›PMID 37442736›Full record

ArticleJournal of dermatological science2023

Reversine enhances skin barrier functions by suppressing the IL-4- and IL-13-mediated STAT6 pathway.

Yukyung Park, Janghwan Jung, Sunmun Jeong, Amy van Ee, Luis A Garza, Minsoo Jang, Dongwon Kim, Jongbin Park

Open access · greenAbstract readLetter
In one paragraph

Article in Journal of dermatological science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yukyung ParkGraduate School of Energy/Biotechnology, Dongseo University, Busan, Republic of Korea.
Janghwan JungDepartment of Dermatology, Kosin University College of Medicine, Busan, Republic of Korea.
Sunmun JeongDepartment of Dermatology, Kosin University College of Medicine, Busan, Republic of Korea.
Amy van EeDepartment of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Luis A GarzaDepartment of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Minsoo JangDepartment of Dermatology, Kosin University College of Medicine, Busan, Republic of Korea.
Dongwon KimGraduate School of Energy/Biotechnology, Dongseo University, Busan, Republic of Korea; Department of Bio-Chemical Engineering, College of Bio-Health Convergence, Dongseo University, Busan, Republic of Korea. Electronic address: dwkim@dongseo.ac.kr.
Jongbin ParkDepartment of Dermatology, Kosin University College of Medicine, Busan, Republic of Korea. Electronic address: dermashining@gmail.com.
Kosin University · KRDongseo University · KRJohns Hopkins University · US

Funding

Medical Scientist Training ProgramT32GM136577 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ANDREA L COX · 2020 to 2026
$13.4M
Retinoic acid synthesis induced by noncoding dsRNA controls RegenerationR01AR074846 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI GARZA, LUIS ANDRES · 2019 to 2023
$2.3M
Towards the clinical testing of dsRNA to promote wound induced hair neogenesisR01AR068280 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI GARZA, LUIS ANDRES · 2016 to 2018
$718k
NIAMS NIH HHS R01 AR068280NIAMS NIH HHS R01 AR074846NIGMS NIH HHS T32 GM136577
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Interleukin-13Interleukin-4MorpholinesPurinesSTAT6 Transcription Factor2-(4-morpholinoanilino)-6-cyclohexylaminopurineInterleukin-13Interleukin-4MorpholinesPurinesSTAT6 Transcription Factor

Identifiers

PMID37442736
PMCPMC10529134
OpenAlexW4382280065

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.